Vertex Pharmaceuticals Stock Price on May 7, 2024
| VRTX Stock | USD 449.18 1.65 0.37% |
Below is the normalized historical share price chart for Vertex Pharmaceuticals extending back to July 24, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vertex Pharmaceuticals stands at 449.18, as last reported on the 23rd of May, with the highest price reaching 449.91 and the lowest price hitting 441.73 during the day.
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. We consider Vertex Pharmaceuticals very steady. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0682, which indicates the firm had a 0.0682% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vertex Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Vertex Pharmaceuticals' Coefficient Of Variation of 1086.53, semi deviation of 0.9032, and Risk Adjusted Performance of 0.0576 to confirm if the risk estimate we provide is consistent with the expected return of 0.0735%.
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024. . At this time, Vertex Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 7.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.12 in 2024. Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 1991 | 200 Day MA 389.118 | 50 Day MA 410.861 | Beta 0.387 |
Vertex |
Sharpe Ratio = 0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | VRTX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.08 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Vertex Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 5.8321 | Enterprise Value Ebitda 20.0037 | Price Sales 10.385 | Shares Float 257.3 M | Wall Street Target Price 467.71 |
Vertex Pharmaceuticals Valuation on May 7, 2024
It is possible to determine the worth of Vertex Pharmaceuticals on a given historical date. On May 7, 2024 Vertex was worth 406.42 at the beginning of the trading date compared to the closed value of 410.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Vertex Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vertex Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vertex Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 402.30 | 407.59 | 401.02 | 402.50 | 1,444,546 | |
05/07/2024 | 406.42 | 415.67 | 394.03 | 410.24 | 1,607,215 |
| 413.33 | 425.65 | 412.12 | 418.82 | 1,605,489 |
| Backtest Vertex Pharmaceuticals | | | Vertex Pharmaceuticals History | | | Vertex Pharmaceuticals Valuation | Previous | Next |
Vertex Pharmaceuticals Trading Date Momentum on May 7, 2024
| On May 08 2024 Vertex Pharmaceuticals was traded for 418.82 at the closing time. The top price for the day was 425.65 and the lowest listed price was 412.12 . The trading volume for the day was 1.6 M. The trading history from May 8, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 2.09% . The trading price change against the current closing price is 7.74% . |
Vertex Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Vertex Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vertex Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vertex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vertex Pharmaceuticals Stock history
Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 260.5 M | 153.1 M | |
| Net Income Applicable To Common Shares | 3.8 B | 4 B |
Vertex Pharmaceuticals Quarterly Net Working Capital |
|
Vertex Pharmaceuticals Stock Technical Analysis
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vertex Pharmaceuticals Period Price Range
Low | May 7, 2024
| High |
406.42 | 410.24 |
Vertex Pharmaceuticals May 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 83672.46 | |||
| Daily Balance Of Power | 0.1765 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 404.85 | |||
| Day Typical Price | 406.65 | |||
| Price Action Indicator | 7.3 | |||
| Period Momentum Indicator | 38.94 |
Vertex Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0576 | |||
| Jensen Alpha | 0.0435 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0209 | |||
| Treynor Ratio | 0.132 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.565 | Earnings Share 15.43 | Revenue Per Share 39.492 | Quarterly Revenue Growth 0.133 | Return On Assets 0.1282 |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.